Company Name: KemPharm Inc.
KemPharm Inc. is a developer of prodrugs. The company uses its Ligand Activated Therapy (LAT) platform to develop improved prodrug versions of existing approved drugs. The company’s most advanced product candidate is designed to be an abuse-deterrent, immediate release treatment for acute moderate to moderately severe pain. The company’s product pipeline includes candidates for ADHD, pain treatment and other central nervous system disorders.
Ticker Symbol: KMPH (NASDAQ)
Company Website: www.kempharm.com
Social Media: KemPharm LinkedIn Page
Headquarters: Coralville, IA